CNO Financial Group, Inc.
NYSE:CNOInsurance - Life
+$0.03 today
- Market cap
- $5.14B
- Beta
- 0.84
- P/E (TTM)
- 19.6
- EPS (TTM)
- $2.61
- Dividend yield
- 1.35%
Volume 0.67M
Average 0.71M
CNO Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
CNO Financial Group, Inc.NYSE: CNO
Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026
Weighted avg shares (diluted) declines year over year
Q2 FY2026 weighted avg shares (diluted) of 94.95M shares fell 7.9% year over year, in line with the -7.8% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.9% from the prior quarter. Over 3 fiscal years it compounded at -6.0% a year.
Context
- Weighted avg shares (diluted) increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -7.9% toward the trailing-twelve-month pace of -7.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
- Latest · FY2025
- 97.76M USD
- Year-over-year change
- -9.6%
- 4-year CAGR
- -7.1%
| Period | Period end | Weighted Avg Shares (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 97.76M | -9.6% |
| FY2024 | 2024-12-31 | 108.12M | -6.1% |
| FY2023 | 2023-12-31 | 115.12M | -2.2% |
| FY2022 | 2022-12-31 | 117.72M | -10.2% |
| FY2021 | 2021-12-31 | 131.13M | — |
Weighted Avg Shares (Diluted) vs competitors
How CNO compares with its peers on the latest reported figures
- CNO's LTM Jun 2026 weighted avg shares (diluted) of 96.23M shares is the 5th highest of the 9 companies compared; the peer median is 91.46M shares.
- Its year-over-year change of -7.8% is the 8th highest of 9, against a peer median of -2.3%.
- Over three fiscal years its annual growth of -6.0% compares with a peer median of -4.1%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | 397.43M | -6.9% | -6.8% | |
| LTM Sep 2026 | 262.1M | -1.4% | +15.4% | |
| LTM Jun 2026 | 136.75M | +6.2% | +4.7% | |
| LTM Sep 2026 | 109.36M | +0.1% | +0.1% | |
| LTM Jun 2026 | 96.23M | -7.8% | -6.0% | |
| LTM Jun 2026 | 73.55M | -5.4% | -4.3% | |
| LTM Sep 2026 | 57.8M | -1.5% | -8.1% | |
| LTM Sep 2026 | 45.93M | -8.2% | -8.2% | |
| LTM Sep 2026 | 44.99M | -3.1% | -3.8% | |
| Peer median (excluding CNO) | 91.46M | -2.3% | -4.1% | |
Competitors are the stored peer set for CNO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.12B | 3.58B | 4.15B | 4.45B | 4.49B |
| Cost of Revenue | 2.42B | 1.79B | 2.61B | 2.74B | 2.48B |
| Gross Profit | 1.7B | 1.79B | 1.53B | 1.7B | 2.01B |
| Gross Margin | 41.2% | 50.1% | 37.0% | 38.3% | 44.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 267.9M | 287.9M | 290.9M | 304.5M | 0 |
| Operating Expenses | 966.3M | 973.7M | 1.18B | 1.18B | 1.72B |
| Depreciation & Amortization | 236.6M | 248.5M | 267.4M | 292.4M | 318.5M |
| EBITDA | 1.07B | 1.2B | 862.8M | 1.07B | 842.8M |
| EBITDA Margin | 25.8% | 33.6% | 20.8% | 24.0% | 18.8% |
| Operating Income | 733.1M | 816.5M | 356.8M | 518.3M | 293.4M |
| Operating Margin | 17.8% | 22.8% | 8.6% | 11.7% | 6.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 95.4M | 137M | 238.6M | 254.4M | 230.9M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 733.1M | 816.5M | 356.8M | 518.3M | 293.4M |
| Pre-Tax Margin | 17.8% | 22.8% | 8.6% | 11.7% | 6.5% |
| Income Tax Expense | 162.8M | 185.9M | 80.3M | 114.3M | 64.1M |
| Net Income | 570.3M | 630.6M | 276.5M | 404M | 229.3M |
| Net Margin | 13.8% | 17.6% | 6.7% | 9.1% | 5.1% |
| EPS (Basic) | 3.43 | 5.45 | 2.44 | 3.81 | 2.35 |
| EPS (Diluted) | 3.36 | 5.36 | 2.40 | 3.74 | 2.35 |
| Weighted Avg Shares | 128.4M | 117.65M | 113.28M | 106.14M | 97.76M |
| Weighted Avg Shares (Diluted) | 131.13M | 117.72M | 115.12M | 108.12M | 97.76M |
CNO Financial Group, Inc.
NYSE:CNO
Intrinsic Alpha fair value
Locked
Current Price
$56.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.